This model variant again shows an increasing trend with age in transient immunity for seropositives, but less so for seronegatives (Figure 5—figure supplement 4 , Table 1 ).
← all excerpts
Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level phase III data.
1
—
—